• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用混合方法估算日本一般人群尿镉致不良肾脏效应的基准剂量。

Application of hybrid approach for estimating the benchmark dose of urinary cadmium for adverse renal effects in the general population of Japan.

机构信息

Department of Occupational and Environmental Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuoku, Chiba 260-8670, Japan.

出版信息

J Appl Toxicol. 2011 Jan;31(1):89-93. doi: 10.1002/jat.1582. Epub 2010 Sep 11.

DOI:10.1002/jat.1582
PMID:20836141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3010323/
Abstract

We used an updated hybrid approach to estimate the benchmark doses and their 95% lower confidence limits (BMDL) for cadmium-induced renal effects in humans. Participants were 828 inhabitants (410 men, 418 women), aged 40-59 years who lived in three areas without any known environmental cadmium pollution. We measured urinary cadmium (U-Cd) as a marker of exposure, and urinary protein, β2-microglobulin (β2-MG) and N-acetyl-β-D-glucosaminidase (NAG) as markers of renal effects. For urinary protein, the BMDL ranged from 0.9 to 1.1 µg g⁻¹  creatinine (cre) and approximately 1.6 µg per 24 h in men, and from 1.9 to 3.4 µg g⁻¹  cre and 2.0 µg per 24 h in women. For the renal tubular markers β2-MG and NAG, the BMDL for U-Cd ranged from 0.6 to 1.2 µg g⁻¹  cre and from 0.8 to 1.7 µg per 24 h in men, and from 0.6 to 2.3 µg g⁻¹  cre and from 0.6 to 2.1 µg per 24 h in women. The lowest BMDL for urinary cadmium (0.6 µg g⁻¹ cre) was somewhat lower than average urinary cadmium in Japanese older population. These results suggest the importance of measures to decrease cadmium exposure in the general population of Japan.

摘要

我们采用了一种更新的混合方法来估计人类镉诱导肾脏效应的基准剂量及其 95%置信下限 (BMDL)。参与者为 828 名居住在三个无已知环境镉污染地区的 40-59 岁居民(410 名男性,418 名女性)。我们测量了尿镉 (U-Cd) 作为暴露标志物,以及尿蛋白、β2-微球蛋白 (β2-MG) 和 N-乙酰-β-D-氨基葡萄糖苷酶 (NAG) 作为肾脏效应标志物。对于尿蛋白,男性的 BMDL 范围为 0.9 至 1.1 μg/g 肌酐 (cre),约为 1.6 μg/24 h,女性的 BMDL 范围为 1.9 至 3.4 μg/g cre 和 2.0 μg/24 h。对于肾小管标志物 β2-MG 和 NAG,U-Cd 的 BMDL 范围为男性的 0.6 至 1.2 μg/g cre 和 0.8 至 1.7 μg/24 h,女性的 0.6 至 2.3 μg/g cre 和 0.6 至 2.1 μg/24 h。尿镉的最低 BMDL(0.6 μg/g cre)略低于日本老年人群的平均尿镉水平。这些结果表明,在日本普通人群中采取措施减少镉暴露的重要性。

相似文献

1
Application of hybrid approach for estimating the benchmark dose of urinary cadmium for adverse renal effects in the general population of Japan.应用混合方法估算日本一般人群尿镉致不良肾脏效应的基准剂量。
J Appl Toxicol. 2011 Jan;31(1):89-93. doi: 10.1002/jat.1582. Epub 2010 Sep 11.
2
Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.基于日本镉未污染地区总蛋白、β2-微球蛋白和N-乙酰-β-D-氨基葡萄糖苷酶的排泄情况,将基准剂量估算为尿镉的阈值水平。
Environ Res. 2006 Jul;101(3):401-6. doi: 10.1016/j.envres.2005.12.002. Epub 2006 Jan 24.
3
Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand.泰国人群的风险评估:通过泰国污染和未污染地区居民的混合方法确定肾脏效应的尿镉和血镉水平基准剂量。
BMC Public Health. 2014 Jul 9;14:702. doi: 10.1186/1471-2458-14-702.
4
Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium.日本一般环境中镉暴露对健康的影响,特别提及作为尿镉阈值水平的基准剂量下限。
Scand J Work Environ Health. 2005 Aug;31(4):307-15. doi: 10.5271/sjweh.887.
5
Reassessment of the threshold of urinary cadmium by using hybrid approach in a cadmium non-polluted area in Japan.日本镉非污染地区应用混合方法重新评估尿镉阈值。
Int J Hyg Environ Health. 2011 Mar;214(2):175-8. doi: 10.1016/j.ijheh.2010.09.002.
6
Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.日本镉未污染地区肾功能障碍基准剂量的估算。
J Appl Toxicol. 2006 Jul-Aug;26(4):351-5. doi: 10.1002/jat.1147.
7
Renal tubular dysfunction increases mortality in the Japanese general population living in cadmium non-polluted areas.肾小管功能障碍会增加生活在镉无污染地区的日本普通人群的死亡率。
J Expo Sci Environ Epidemiol. 2015 Jul-Aug;25(4):399-404. doi: 10.1038/jes.2014.44. Epub 2014 Jun 18.
8
Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.基于日本镉污染地区和非污染地区β2-微球蛋白的排泄情况,将基准剂量估算为尿镉的阈值水平。
Toxicol Lett. 2008 Jun 30;179(2):108-12. doi: 10.1016/j.toxlet.2008.04.013.
9
Variation in benchmark dose (BMD) and the 95% lower confidence limit of benchmark dose (BMDL) among general Japanese populations with no anthropogenic exposure to cadmium.在没有人为接触镉的情况下,普通日本人群体中基准剂量(BMD)和 95%置信下限的基准剂量(BMDL)存在差异。
Int Arch Occup Environ Health. 2012 Nov;85(8):941-50. doi: 10.1007/s00420-012-0734-z. Epub 2012 Jan 24.
10
Estimation of Benchmark Dose of Lifetime Cadmium Intake for Adverse Renal Effects Using Hybrid Approach in Inhabitants of an Environmentally Exposed River Basin in Japan.应用混合方法估算日本受镉污染河流流域居民一生中镉摄入的基准剂量与不良肾脏效应。
Risk Anal. 2017 Jan;37(1):20-26. doi: 10.1111/risa.12750. Epub 2017 Jan 11.

引用本文的文献

1
The Validity of Benchmark Dose Limit Analysis for Estimating Permissible Accumulation of Cadmium.基准剂量限值分析估计镉容许蓄积量的有效性。
Int J Environ Res Public Health. 2022 Nov 25;19(23):15697. doi: 10.3390/ijerph192315697.
2
Effects of IL-4-590C/T (rs2243250) Polymorphism on the Susceptibility of Smoking-Related Cancer: A Meta-Analysis Involving 11,407 Subjects.IL-4-590C/T(rs2243250)多态性对吸烟相关癌症易感性的影响:一项涉及 11407 例个体的荟萃分析。
Biomed Res Int. 2019 Dec 2;2019:3104176. doi: 10.1155/2019/3104176. eCollection 2019.
3
Phylogenetic, comparative genomic and structural analyses of human Streptococcus agalactiae ST485 in China.中国人类无乳链球菌 ST485 的系统发育、比较基因组学和结构分析。
BMC Genomics. 2018 Sep 27;19(1):716. doi: 10.1186/s12864-018-5084-0.
4
Benchmark dose for cadmium exposure and elevated N-acetyl-β-D-glucosaminidase: a meta-analysis.镉暴露与N-乙酰-β-D-氨基葡萄糖苷酶升高的基准剂量:一项荟萃分析。
Environ Sci Pollut Res Int. 2016 Oct;23(20):20528-20538. doi: 10.1007/s11356-016-7214-z. Epub 2016 Jul 27.
5
Associations of Low Environmental Exposure to Multiple Metals with Renal Tubular Impairment in Korean Adults.韩国成年人低环境多金属暴露与肾小管损伤的关联。
Toxicol Res. 2016 Jan;32(1):57-64. doi: 10.5487/TR.2016.32.1.057. Epub 2016 Jan 31.
6
Benchmark Dose for Urinary Cadmium based on a Marker of Renal Dysfunction: A Meta-Analysis.基于肾功能障碍标志物的尿镉基准剂量:一项荟萃分析。
PLoS One. 2015 May 13;10(5):e0126680. doi: 10.1371/journal.pone.0126680. eCollection 2015.
7
Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand.泰国人群的风险评估:通过泰国污染和未污染地区居民的混合方法确定肾脏效应的尿镉和血镉水平基准剂量。
BMC Public Health. 2014 Jul 9;14:702. doi: 10.1186/1471-2458-14-702.
8
Application of BMD approach to identify thresholds of cadmium-induced renal effect among 35 to 55 year-old women in two cadmium polluted counties in China.应用骨密度方法在中国两个镉污染县的35至55岁女性中确定镉诱导肾效应的阈值。
PLoS One. 2014 Feb 4;9(2):e87817. doi: 10.1371/journal.pone.0087817. eCollection 2014.
9
Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis.饮食类黄酮摄入与吸烟相关癌症风险:一项荟萃分析。
PLoS One. 2013 Sep 19;8(9):e75604. doi: 10.1371/journal.pone.0075604. eCollection 2013.
10
Prioritizing hazardous pollutants in two Nigerian water supply schemes: a risk-based approach.优先考虑尼日利亚两个供水系统中的危险污染物:基于风险的方法。
Bull World Health Organ. 2013 Aug 1;91(8):553-561J. doi: 10.2471/BLT.12.115774. Epub 2013 May 31.

本文引用的文献

1
Population toxicokinetic modeling of cadmium for health risk assessment.用于健康风险评估的镉的群体毒代动力学建模。
Environ Health Perspect. 2009 Aug;117(8):1293-301. doi: 10.1289/ehp.0800317. Epub 2009 May 6.
2
Current status of cadmium as an environmental health problem.镉作为一个环境卫生问题的现状。
Toxicol Appl Pharmacol. 2009 Aug 1;238(3):201-8. doi: 10.1016/j.taap.2009.04.020. Epub 2009 May 3.
3
Biological half-life of cadmium in the urine of inhabitants after cessation of cadmium exposure.停止镉暴露后居民尿液中镉的生物学半衰期。
Biomarkers. 2009 Mar;14(2):77-81. doi: 10.1080/13547500902730698.
4
Estimation of benchmark doses as threshold levels of urinary cadmium, based on excretion of beta2-microglobulin in cadmium-polluted and non-polluted regions in Japan.基于日本镉污染地区和非污染地区β2-微球蛋白的排泄情况,将基准剂量估算为尿镉的阈值水平。
Toxicol Lett. 2008 Jun 30;179(2):108-12. doi: 10.1016/j.toxlet.2008.04.013.
5
The current state of knowledge on the use of the benchmark dose concept in risk assessment.风险评估中基准剂量概念应用的当前知识状态。
J Appl Toxicol. 2008 May;28(4):405-21. doi: 10.1002/jat.1298.
6
Estimation of benchmark doses for urinary cadmium based on beta2-microglobulin excretion in cadmium-polluted regions of the Kakehashi River basin, Japan.基于日本柿川河流域镉污染地区β2-微球蛋白排泄量估算尿镉的基准剂量
Int J Environ Health Res. 2006 Oct;16(5):329-37. doi: 10.1080/09603120600869174.
7
Benchmark dose for cadmium-induced renal effects in humans.镉对人体肾脏影响的基准剂量。
Environ Health Perspect. 2006 Jul;114(7):1072-6. doi: 10.1289/ehp.9028.
8
Estimation of benchmark dose for renal dysfunction in a cadmium non-polluted area in Japan.日本镉未污染地区肾功能障碍基准剂量的估算。
J Appl Toxicol. 2006 Jul-Aug;26(4):351-5. doi: 10.1002/jat.1147.
9
Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium.日本一般环境中镉暴露对健康的影响,特别提及作为尿镉阈值水平的基准剂量下限。
Scand J Work Environ Health. 2005 Aug;31(4):307-15. doi: 10.5271/sjweh.887.
10
The benchmark dose method--review of available models, and recommendations for application in health risk assessment.基准剂量法——现有模型综述及在健康风险评估中的应用建议。
Crit Rev Toxicol. 2003;33(5):505-42.